Overview
- 15 inspections across 15 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-07.
At a glance
Inspections
15
Sites
15
Observations
0
Career since
Jun 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Octapharma Plasma Inc | 7 May 2026 | Biologics | |
| KEDPLASMA LLC | 5 Feb 2026 | Biologics | |
| Kedplasma LLC | 3 Feb 2026 | Biologics | On file |
| Octapharma Plasma Inc | 15 Jan 2026 | Biologics | |
| Octapharma Plasma Inc | 26 Sep 2025 | Biologics |
Sites inspected
Octapharma Plasma IncMerced, United States1 insp.
KEDPLASMA LLCPort Orange, United States1 insp.
Kedplasma LLCOrlando, United States1 insp.
Octapharma Plasma IncTulare, United States1 insp.
Octapharma Plasma IncRiverside, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Christi Ann L Samella2 shared
Camilla S Smith2 shared
Catherine L Mcgraw1 shared
Patricia E Weddington1 shared
Racquel N East1 shared
Barbara G Peoples1 shared
Full investigator report
Get the verbatim findings behind Mona B Amin's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site